EUVIMEDEUVIMED entdecken
Crossref

Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies

Nicholas Moro, Stanislas Francois, Christel Grondin, Sirine Ben Salem, Sreekanth Rajagopal, Duru Aykut, Louisa Arezki, José Manuel Larramendi, Claire Berquet, Marjolaine Willems iD, Céline Bouchet-Séraphin, Lucas W Gauthier und 9 weitere

Journal of the Peripheral Nervous System · 2026-06 · 31 (2)

DOI: 10.1111/jns.70122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 22.04.2026. Verfasst von Nicholas Moro und 20 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Service de Biochimie Métabolique et Cellulaire, Hôpital Bichat, Paris, France. Hauptthemen laut MEDLINE: L-Iditol 2-Dehydrogenase, Erythrocytes, Peripheral Nervous System Diseases. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims To develop an assay to measure red blood cell (RBC) sorbitol dehydrogenase (SORD) activity for fast laboratory screening of SORD‐related neuropathies, and to provide additional phenotypic arguments in case of ambiguous genetic results.

Methods

Hemolysates were incubated in the presence of fructose and NADH to produce sorbitol and NAD + . The decrease in absorbance at λ = 340 nm was monitored throughout the course of the reaction. Results were expressed as % activity compared to a within‐run control. A cohort of 38 individuals was evaluated over 13 runs: 13 individuals served as within‐run controls, 3 were diagnosed with SORD deficiency, 2 were highly suspected of having SORD deficiency, 1 exhibited incidental genomic findings in the SORD gene, and 19 presented with neuropathy or myopathy of undetermined etiology.

Results

RBC SORD activity was significantly reduced in individuals diagnosed with SORD deficiency when compared to within‐run controls, whereas in contrast, individuals without SORD deficiency did not exhibit this reduction. A comparison of these two groups showed that activities were significantly lower in deficient individuals ( p = 0.00006). A test cutoff of < 30% yielded 100% sensitivity and specificity to detect deficient individuals.

Interpretation

This test provides a useful alternative to measuring plasma or urine sorbitol with mass spectrometry, allowing clinicians to directly evaluate SORD activity in RBC. As a result, it enables quick and convenient screening for SORD‐related neuropathies during standard clinical procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

L-Iditol 2-DehydrogenaseErythrocytesPeripheral Nervous System DiseasesHumansFemaleMale

Stichwörter der Autor:innen

CMT2SORDdHMNsorbitol

Substanzen

L-Iditol 2-Dehydrogenase

Autor:innen und Institutionen

  • AP-HP, Service de Biochimie Métabolique et Cellulaire, Hôpital Bichat, Paris, France.
  • Département de Biochimie-Pharmacologie, Hôpital Universitaire Henri Mondor, AP-HP; INSERM U955, Université Paris-Est-Créteil, France.
  • Department of Clinical Genetics, Arnaud de Villeneuve Hospital, University Hospital of Montpellier, Montpellier, France.
  • Institute for Neurosciences of Montpellier, Montpellier, France.
  • Laboratoire AURAGEN, Service de Génétique, Lyon, France.
  • Laboratoire de Génétique, GHU AP-HP Hôpitaux Universitaires Henri-Mondor, Créteil, France.

ORCID-Profile: Marjolaine Willems, Katell Peoc'h, Arnaud Bruneel, Alexandre Raynor

Zitieren

APA

Moro, N., Francois, S., Grondin, C., Ben Salem, S., Rajagopal, S., Aykut, D., Arezki, L., Larramendi, J. M., Berquet, C., Willems, M., Bouchet-Séraphin, C., Gauthier, L. W., Konyukh, M., Svahn, J., Moutereau, S., Peoc'h, K., Tard, C., Fernández-Eulate, G., Stojkovic, T., …, & Raynor, A. (2026). Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies. Journal of the Peripheral Nervous System, 31(2). https://doi.org/10.1111/jns.70122

Vancouver

Moro N, Francois S, Grondin C, Ben Salem S, Rajagopal S, Aykut D, et al. Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies. Journal of the Peripheral Nervous System. 2026;31(2). doi:10.1111/jns.70122

BibTeX
@article{Moro2026,
  author = {Moro, Nicholas and Francois, Stanislas and Grondin, Christel and Ben Salem, Sirine and Rajagopal, Sreekanth and Aykut, Duru and Arezki, Louisa and Larramendi, José Manuel and Berquet, Claire and Willems, Marjolaine and Bouchet-Séraphin, Céline and Gauthier, Lucas W and Konyukh, Marina and Svahn, Juliette and Moutereau, Stéphane and Peoc'h, Katell and Tard, Céline and Fernández-Eulate, Gorka and Stojkovic, Tanya and Bruneel, Arnaud and Raynor, Alexandre},
  title = {Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  volume = {31},
  number = {2},
  doi = {10.1111/jns.70122}
}
Kostenlos starten →